Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In a first step in transgenic organ transplants, a pig heart expressing complement-inhibiting proteins was transplanted into
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury